Xi'an Wanlong pharmaceutical Co., Ltd

Business Type:Manufacturer

Main Products:API,Intermediates,Formulations finished products,Tablets injection capsule,Tirofiban Hydrochloride,Epalrestat,Moxonidine,Dextran 40,Ubenimex,Alanyl glutamine

Country/Region:China

Annual Revenue:200000000 RMB

Main Markets:North America,South America,Eastern Europe,Southeast Asia,Africa,Oceania,Mid East,Eastern Asia,Western Europe,

Ddu Verified

HOT Rank

6/10
Company Information

Xi’an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates. The company’s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements.

There are more than 700 employees including over 70 RD staffs20 experienced production management people and 8 senior professional registration specialists.  Having a dynamic, high-quality team, which ensures our company sustainable and stable development.

We produce tablets, capsule, granules, injection and API, total 49 drug approval numbers and other intermediates. There are 4 API workshops, and two solid preparation plants, injection plants with GMP. Annual production capacity of 100 tons of raw material, solid dosage form annual output of 3 billion, injection annual output 1.3 billion bags. The drug products are widely used in the most provinces of china, and API exports to all over the world.

 We have the rights of self-operated import and export and welcome the clients around the world to cooperate with us.


Email to this supplier
To

Send

Inquiry Cart(0)